Home Diabetes Tags

View the Latest: Diabetes

Filter

List Grid

11 - 20 of 24 Results

  • A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity

    Issue Brief

    The FDA recently approved a new use for Wegovy, the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese - a decision that opens the door to Medicare coverage of Wegovy, which is prohibited by law from covering drugs used for obesity. This brief analyses how many Medicare beneficiaries could be eligible for the new use of Wegovy and the potential impact on Medicare spending.

  • KFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs

    Feature

    About half of adults are interested in taking prescription weight loss drugs. though interest drops when presented with obstacles or drawbacks. Many adults struggle with affording prescription drugs and say there should be more price regulation. Few are aware of provisions in the 2023 Inflation Reduction Act aimed at lowering the drug price for Medicare beneficiaries

  • Out-of-pocket spending on insulin among people with private insurance

    Issue Brief

    This analysis of insurance claims data finds that Congressional proposals to set a $35 per month cap on what people pay out of pocket for insulin would provide financial relief to at least 1 out of 5 insulin users with different types of private health insurance.

  • How Have Diabetes Costs and Outcomes Changed Over Time in the U.S.?

    Feature

    In 2017, 7.2% of the U.S. population was diagnosed with diabetes - an 188% increase from 1980. This slideshow documents trends in health outcomes, quality of care, and spending on treatment for people in the U.S. with diabetes. It also looks at the costs of medications for treating diabetes, and U.S. health spending related to endocrine diseases.

  • How Much Does Medicare Spend on Insulin?

    Issue Brief

    The price of insulin, used by people with both Type 1 and Type 2 diabetes to control blood glucose levels, has come under increasing scrutiny as policymakers grapple with rising drug costs. This data note finds spending on insulin by Medicare and beneficiaries enrolled in private Part D drug plans has increased sharply between 2007 and 2017.

  • The Diseases We Spend Our Health Dollars On

    News Release

    In his latest column for The Wall Street Journal's Think Tank, Drew Altman explains how a recent Bureau of Economic Analysis report makes the nation’s health care spending more tangible by breaking it down by disease. All previous columns by Drew Altman are available online.

  • The Diseases We Spend Our Health Dollars On

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman explains how a recent Bureau of Economic Analysis report makes the nation’s health care spending more tangible by breaking it down by disease.